Live
10x Genomics BlogARK Investment Increases Stake in 10x Genomics (TXG) with Major Purchase - GuruFocusEndpoints NewsTurmoil at ACIP continues after claim committee ‘disbanded’ is quickly refuted10x Genomics BlogCathie Wood’s ARK adds 10x Genomics stock, trims Arcturus By Investing.com - Investing.com AustraliaFierceBiotechEmbecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulinIlluminaA Look At Labcorp Holdings (LH) Valuation After Expanded Illumina Precision Oncology Alliance - simplywall.stLonza NewsLonza Group AG stock faces pressure amid Swiss trade data and transformation completion - AD HOC NEWSLonza NewsLonza Group AG stock faces pressure amid Swiss trade data and transformation completion - AD HOC NEWSEndpoints NewsTech talent comes to healthcareCellThermodynamic prediction of RNA cellular activity from sequence via conformational ensemblesCellContextual computation by competitive protein dimerization networksCellTransplantation of encapsulated mitochondria alleviates dysfunction in mitochondrial and Parkinson’s disease modelsFierceBiotechPfizer adds to Seagen scrap heap with another early cancer candidate cull
FierceBiotech Jan 23, 2026

Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials

Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials

Original
Body unavailable. Use the original source.

Directory

59 All